Loading clinical trials...

Serum Immunological Profiles in Head and Neck Cancer Patients Receiving Curative Radiotherapy | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNCT03325036

Serum Immunological Profiles in Head and Neck Cancer Patients Receiving Curative Radiotherapy

The purpose of the study is to investigate the clinical usefulness of serum levels of immunologic profiles including pro/anti-inflammatory interleukins, other detectable serum biomarkers including tra...

Lead sponsor: National Taiwan University Hospital•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment60

Start dateJul 2017

Last updatedDec 4, 2025

Condition

Head and Neck Cancers Patients

Locations shown

National Taiwan University Hospital

Taipei

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 4, 2025Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions